{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:34:53Z","timestamp":1790634893452,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["184.034.019"],"award-info":[{"award-number":["184.034.019"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.tranon.2025.102464","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:37:14Z","timestamp":1751384234000},"page":"102464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade"],"prefix":"10.1016","volume":"59","author":[{"given":"Alexander","family":"Constantinides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Lansu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulien","family":"Rauwerdink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Strating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"V\u00f6llmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Nederend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette H.W.","family":"Leusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Rovers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Wassenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Lurvink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Altelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Nienhuijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Wiezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inne H.M.","family":"Borel Rinkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamila","family":"Boerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert J.P.L.","family":"Kops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2112-4390","authenticated-orcid":false,"given":"Onno","family":"Kranenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2025.102464_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.650098","article-title":"Peritoneal metastases from colorectal cancer: defining and addressing the challenges","volume":"11","author":"Kranenburg","year":"2021","journal-title":"Front. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.tranon.2025.102464_bib0002","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.21037\/jgo-20-257","article-title":"Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic review","volume":"12","author":"Lurvink","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"issue":"7","key":"10.1016\/j.tranon.2025.102464_bib0003","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2025.102464_bib0004","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Quenet","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tranon.2025.102464_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2021.05.023","article-title":"de Hingh I. The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: a web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)","author":"van de Vlasakker","year":"2021","journal-title":"J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"key":"10.1016\/j.tranon.2025.102464_bib0006","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-020-09558-4","article-title":"Pressurized intraperitoneal aerosol chemotherapy (Oxaliplatin) for unresectable colorectal peritoneal metastases: a multicenter, single-arm, phase II trial (CRC-PIPAC)","author":"Rovers","year":"2021","journal-title":"Ann. Surg. Oncol."},{"issue":"7197","key":"10.1016\/j.tranon.2025.102464_bib0007","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/453843a","article-title":"Translational research: the full cycle","volume":"453","author":"Ledford","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.tranon.2025.102464_bib0008","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41588-019-0399-6","article-title":"Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids","volume":"51","author":"Bolhaqueiro","year":"2019","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.tranon.2025.102464_bib0009","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.tranon.2025.102464_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.680435","article-title":"An eight-gene hypoxia signature predicts survival in pancreatic cancer and is associated with an immunosuppressed tumor microenvironment","volume":"12","author":"Abou Khouzam","year":"2021","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.tranon.2025.102464_bib0011","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-11-1182","article-title":"Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer","volume":"71","author":"Toustrup","year":"2011","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.tranon.2025.102464_bib0012","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.18632\/oncotarget.2285","article-title":"A generic cycling hypoxia-derived prognostic gene signature: application to breast cancer profiling","volume":"5","author":"Boidot","year":"2014","journal-title":"Oncotarget"},{"issue":"25","key":"10.1016\/j.tranon.2025.102464_bib0013","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1074\/jbc.M901790200","article-title":"Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts","volume":"284","author":"Mole","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tranon.2025.102464_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.828875","article-title":"The effect of hypoxia and hypoxia-associated pathways in the regulation of antitumor response: friends or foes?","volume":"13","author":"Abou Khouzam","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.tranon.2025.102464_bib0015","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.tranon.2025.102464_bib0016","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41587-021-00896-6","article-title":"Gene signature extraction and cell identity recognition at the single-cell level with cell-ID","volume":"39","author":"Cortal","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102464_bib0017","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.it.2022.01.003","article-title":"Unraveling B cell trajectories at single cell resolution","volume":"43","author":"Morgan","year":"2022","journal-title":"Trends. Immunol."},{"issue":"12","key":"10.1016\/j.tranon.2025.102464_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11122002","article-title":"JAK-STAT signaling: a double-edged sword of immune regulation and cancer progression","volume":"11","author":"Owen","year":"2019","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.tranon.2025.102464_bib0019","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0092-8674(95)90311-9","article-title":"Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation","volume":"82","author":"Wen","year":"1995","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.tranon.2025.102464_bib0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0968-0004(94)90026-4","article-title":"Signaling by the cytokine receptor superfamily: jAKs and STATs","volume":"19","author":"Ihle","year":"1994","journal-title":"Trends. Biochem. Sci."},{"key":"10.1016\/j.tranon.2025.102464_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.830208","article-title":"Key players of the immunosuppressive tumor microenvironment and emerging therapeutic strategies","volume":"10","author":"Park","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tranon.2025.102464_bib0022","article-title":"Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma","author":"Coleman","year":"2022","journal-title":"Mol. Carcinog."},{"issue":"7","key":"10.1016\/j.tranon.2025.102464_bib0023","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"Sautes-Fridman C. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102464_bib0024","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2025.102464_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113735","article-title":"Borel Rinkes I, Kranenburg O pre-existing subclones determine radioresistance in rectal cancer organoids","author":"Andel","year":"2024","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.tranon.2025.102464_bib0026","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1245\/s10434-020-09558-4","article-title":"Pressurized intraperitoneal aerosol chemotherapy (Oxaliplatin) for unresectable colorectal peritoneal metastases: a multicenter, single-arm, phase II trial (CRC-PIPAC)","volume":"28","author":"Rovers","year":"2021","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102464_bib0027","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2020.02.015","article-title":"Complement signals determine opposite effects of B cells in chemotherapy-induced immunity","volume":"180","author":"Lu","year":"2020","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.tranon.2025.102464_bib0028","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/cas.14023","article-title":"Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma","volume":"110","author":"Kuwabara","year":"2019","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.tranon.2025.102464_bib0029","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1583547","article-title":"APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures","volume":"8","author":"Morcrette","year":"2019","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.tranon.2025.102464_bib0030","first-page":"765","article-title":"Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosis","volume":"479","author":"Benzerdjeb","year":"2021","journal-title":"Int. J. Pathol."},{"issue":"12","key":"10.1016\/j.tranon.2025.102464_bib0031","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41571-020-0413-z","article-title":"Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors","volume":"17","author":"Galluzzi","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102464_bib0032","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-16-0081","article-title":"A strong B-cell response is part of the immune landscape in Human high-grade serous ovarian metastases","volume":"23","author":"Montfort","year":"2017","journal-title":"Off. J. Am. Assoc. Cancer Res."},{"issue":"12","key":"10.1016\/j.tranon.2025.102464_bib0033","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Off. J. Am. Assoc. Cancer Res."},{"issue":"7850","key":"10.1016\/j.tranon.2025.102464_bib0034","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","article-title":"IgA transcytosis and antigen recognition govern ovarian cancer immunity","volume":"591","author":"Biswas","year":"2021","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.tranon.2025.102464_bib0035","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1084\/jem.20020338","article-title":"Inducing tumor immunity through the selective engagement of activating fcgamma receptors on dendritic cells","volume":"195","author":"Kalergis","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tranon.2025.102464_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.913215","article-title":"From CD16a biology to antibody-dependent cell-mediated cytotoxicity improvement","volume":"13","author":"Coenon","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102464_bib0037","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cell.2020.10.021","article-title":"Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front","volume":"183","author":"Schurch","year":"2020","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.tranon.2025.102464_bib0038","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1158\/1078-0432.CCR-13-2590","article-title":"Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers","volume":"20","author":"Di Caro","year":"2014","journal-title":"Off. J. Am. Assoc. Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2025.102464_bib0039","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200851","article-title":"Sautes-Fridman C. B cells and cancer: to B or not to B?","volume":"218","author":"Fridman","year":"2021","journal-title":"J. Exp. Med."},{"issue":"7791","key":"10.1016\/j.tranon.2025.102464_bib0040","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"issue":"7791","key":"10.1016\/j.tranon.2025.102464_bib0041","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"7791","key":"10.1016\/j.tranon.2025.102464_bib0042","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.tranon.2025.102464_bib0043","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41577-020-0275-8","article-title":"Dissecting the mechanisms of immune checkpoint therapy","volume":"20","author":"Sharma","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"23","key":"10.1016\/j.tranon.2025.102464_bib0044","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Investigators K-. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andre","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.tranon.2025.102464_bib0045","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(22)00197-8","article-title":"Investigators K-. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study","volume":"23","author":"Diaz","year":"2022","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102464_bib0046","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/bjc.2016.161","article-title":"Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers","volume":"115","author":"Kim","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2025.102464_bib0047","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat. Med."},{"issue":"6230","key":"10.1016\/j.tranon.2025.102464_bib0048","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"issue":"10294","key":"10.1016\/j.tranon.2025.102464_bib0049","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.tranon.2025.102464_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103681","article-title":"Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes","volume":"9","author":"Sundar","year":"2024","journal-title":"ESMo Open."},{"issue":"12","key":"10.1016\/j.tranon.2025.102464_bib0051","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005345","article-title":"Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice","volume":"10","author":"Kucukkose","year":"2022","journal-title":"J. ImmunOther Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2025.102464_bib0052","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004001","article-title":"Ascites and resistance to immune checkpoint inhibition in dMMR\/MSI-H metastatic colorectal and gastric cancers","volume":"10","author":"Fuca","year":"2022","journal-title":"J. ImmunOther Cancer"},{"issue":"7","key":"10.1016\/j.tranon.2025.102464_bib0053","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ccell.2021.05.006","article-title":"Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity","volume":"39","author":"Chow","year":"2021","journal-title":"Cancer Cell."},{"issue":"10","key":"10.1016\/j.tranon.2025.102464_bib0054","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/bjs.11206","article-title":"Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy","volume":"106","author":"Ubink","year":"2019","journal-title":"Br. J. Surg."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:29:48Z","timestamp":1762597788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325001950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":54,"alternative-id":["S1936523325001950"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102464","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102464"}}